PROCEPT BioRobotics Stock
Medical device company
Sign up today and learn more about PROCEPT BioRobotics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About PROCEPT BioRobotics Stock
PROCEPT BioRobotics is a clinical-stage medical device company based in Silicon Valley. The Company has developed a disruptive surgical product for transurethral resection of prostate tissue – The AquaBeam® – and other treatment and diagnostic applications. The AquaBeam is a personalized image-guided tissue removal system, which utilizes proprietary heat-free high-velocity waterjet technology to resect and remove a predetermined volume of tissue with precise and automated incisions conforming to the shape of the prostate.
Co-Founder & Chief Executive Officer
Chief Financial Officer